Global Biotech Laboratories vs Sinopep-Allsino Biopharmaceutical Co., Ltd.

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/globalbiotechlaboratories/sinopep

Category	Global Biotech Laboratories	Sinopep-Allsino Biopharmaceutical Co., Ltd.
Listed site	cdmo	cdmo
Summary	Global Biotech Laboratories is a peptide and oligonucleotide CDMO offering end-to-end contract development and manufacturing from route scouting through validated commercial supply, with cGMP and ICH Q7 compliance across manufacturing sites on three continents.	GMP peptide and oligonucleotide CDMO offering custom synthesis, NCE development, CMC manufacturing, and finished dosage form formulation services for therapeutic programs.
Services	Peptide Manufacturing Oligonucleotide Manufacturing Process Development CMC Analytical Development Formulation Development Stability Testing & Storage Quality Control Testing Technology Transfer CMC Regulatory Submission Support API Synthesis & Manufacturing Cold-Chain Storage & Logistics	Peptide Manufacturing Oligonucleotide Manufacturing Formulation Development Process Development CMC Analytical Development CMC Regulatory Submission Support
Modalities	Peptide Oligonucleotide	Peptide Oligonucleotide
Indications	Data not yet provided.	Data not yet provided.
Locations	Boston, Boston, Massachusetts, United States San Diego, San Diego, California, United States Basel, Basel, Basel-Stadt, Switzerland Dublin, Dublin, Dublin, Ireland Singapore, Singapore, Singapore, Singapore Tokyo, Tokyo, Tokyo, Japan	Data not yet provided.
Certifications	ISO · Identifier: ISO 9001:2015 ISO · Identifier: ISO 13485 FDA · Identifier: FDA Registered EMA · Identifier: EMA Compliant ICH · Identifier: ICH Q7	Data not yet provided.
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.